The risk of Kawasaki disease after pneumococcal conjugate & meningococcal B vaccine in England: A self-controlled case-series analysis
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young childrenScientific Reports, 2019
- Kawasaki disease and 13-valent pneumococcal conjugate vaccination among young children: A self-controlled risk interval and cohort study with null resultsPLOS Medicine, 2019
- Kawasaki disease and immunisation: A systematic reviewVaccine, 2017
- Three episodes of Kawasaki disease including one after the Pneumo 23 vaccine in a child with a family history of Kawasaki diseaseJournal of the Formosan Medical Association, 2016
- Kawasaki disease incidence in children and adolescents: an observational study in primary careBritish Journal of General Practice, 2016
- The first case of Kawasaki disease in a 20-month old baby following immunization with rotavirus vaccine and hepatitis A vaccine in China: A case reportHuman Vaccines & Immunotherapeutics, 2015
- Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in childrenVaccine, 2013
- Kawasaki diseaseProceedings of the Japan Academy, Series B, 2006
- Control without separate controls: evaluation of vaccine safety using case-only methodsVaccine, 2004
- Kawasaki disease in an infant following immunisation with hepatitis B vaccineClinical Rheumatology, 2003